Company / Net Income
Perspective Therapeutics, Inc. Net Income History
FY2013-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$7.3M
FY2022
5-year range
-$7.3M / -$4.7M
FY2018-FY2022
Trend
-41.4%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Income has fluctuated over the past 10 years, ranging from -$7M in FY2022 to -$3M in FY2013.
Based on SEC 10-K filings.
-$7M in FY2022.
Declined from -$7M to -$7M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, net income decreased 41.4% year-over-year.
- Peak net income was recorded in FY2013.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 5.43 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | -$7.3M | -41.4% |
| FY2021 | -$5.1M | +23.2% |
| FY2020 | -$6.7M | -8.7% |
| FY2019 | -$6.2M | -30.8% |
| FY2018 | -$4.7M | -28.0% |
| FY2017 | -$3.7M | +38.2% |
| FY2016 | -$6.0M | -54.5% |
| FY2015 | -$3.9M | +0.0% |
| FY2014 | -$3.9M | -10.5% |
| FY2013 | -$3.5M | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026